399
Views
2
CrossRef citations to date
0
Altmetric
Studies in Humans

Effects of short-term supplementation with bovine lactoferrin and/or immunoglobulins on body mass and metabolic measures: a randomised controlled trial

, , , , &
Pages 219-226 | Received 28 Jun 2016, Accepted 10 Aug 2016, Published online: 04 Sep 2016

References

  • Australian Bureau of Statistics. 2013. Australian Health Survey: Biomedical Results for Chronic Diseases, 2011-12. 4364.0.55.005.
  • Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 101:15718–15723.
  • Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. 2006. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 17:4–12.
  • Brimelow RE, West NP, Williams LT, Cripps AW, Cox AJ. 2015. A role for whey-derived lactoferrin and immunoglobulins in the attenuation of obesity-related inflammation and disease? Crit Rev Food Sci Nutr. [Epub ahead of print]. doi: 10.1080/10408398.2014.995264.
  • Cox AJ, West NP, Cripps AW. 2015. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 3:207–215.
  • Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S, Jobin C, Lund PK. 2010. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One. 5:e12191.
  • Earnest CP, Jordan AN, Safir M, Weaver E, Church TS. 2005. Cholesterol-lowering effects of bovine serum immunoglobulin in participants with mild hypercholesterolaemia. Am J Clin Nutr. 81:792–798.
  • Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. 2007. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 56:1010–1013.
  • Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:499–502.
  • Grundy SM, Brewer HB, Jr., Cleeman JI, Smith SC, Jr., Lenfant C, American Heart A, National Heart L, Blood I. 2004. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 109:433–438.
  • Guarner F, Malagelada JR. 2003. Gut flora in health and disease. Lancet. 361:512–519.
  • Latorre D, Puddu P, Valenti P, Gessani S. 2010. Reciprocal interactions between lactoferrin and bacterial endotoxins and their role in the regulation of the immune response. Toxins. 2:54–68.
  • Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature. 444:1022–1023.
  • Ling JM, Schryvers AB. 2006. Perspectives on interactions between lactoferrin and bacteria. Biochem Cell Biol. 84:275–281.
  • Marette A. 2002. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care. 5:377–383.
  • Mastromarino P, Capobianco D, Campagna G, Laforgia N, Drimaco P, Dileone A, Baldassarre ME. 2014. Correlation between lactoferrin and beneficial microbiota in breast milk and infant's feces. Biometals. 27:1077–1086.
  • Moreno-Navarrete JM, Ortega FJ, Bassols J, Castro A, Ricart W, Fernandez-Real JM. 2008. Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status. Clin Chem. 54:301–309.
  • Mulder AM, Connellan PA, Oliver CJ, Morris CA, Stevenson LM. 2008. Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males. Nutr Res. 28:583–589.
  • Ono T, Murakoshi M, Suzuki N, Iida N, Ohdera M, Iigo M, Yoshida T, Sugiyama K, Nishino H. 2010. Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. Br J Nutr. 104:1688–1695.
  • Perez-Bosque A, Miro L, Maijo M, Polo J, Campbell J, Russell L, Crenshaw J, Weaver E, Moretó M. 2015. Dietary intervention with serum-derived bovine immunoglobulins protects barrier function in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol. 308:G1012–G1018.
  • R Core Team. 2015. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
  • Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, Hardt PD. 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 18:190–195.
  • Tilg H, Moschen AR, Kaser A. 2009. Obesity and the microbiota. Gastroenterology. 136:1476–1483.
  • Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, et al. 2009. A core gut microbiome in obese and lean twins. Nature. 457:480–484.
  • Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444:1027–1031.
  • Ward PP, Paz E, Conneely OM. 2005. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci. 62:2540–2548.
  • Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science. 334:105–108.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.